Limits...
Summary of third Nordic symposium on digital pathology.

Lundström C, Waltersson M, Persson A, Treanor D - J Pathol Inform (2016)

Bottom Line: Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits.This article is a summary of the third NDP symposium in Linkφping, Sweden.This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use.

View Article: PubMed Central - PubMed

Affiliation: Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden, UK.

ABSTRACT
Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits. The Nordic symposium on digital pathology (NDP) was created to promote knowledge exchange in this area, among stakeholders in health care, industry, and academia. This article is a summary of the third NDP symposium in Linkφping, Sweden. The Nordic experiences, including several hospitals using whole-slide imaging for substantial parts of their primary reviews, formed a fertile base for discussions among the 190 NDP attendees originating from 15 different countries. This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use.

No MeSH data available.


Perceived confidence in different sources of safety assurances regarding digital pathology. Personal experience and high-quality trials are considered the most trustworthy sources
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4837798&req=5

Figure 7: Perceived confidence in different sources of safety assurances regarding digital pathology. Personal experience and high-quality trials are considered the most trustworthy sources

Mentions: Validation can be performed, documented, and disseminated in many ways and by several types of stakeholders. As the decision to adopt digital pathology often boils down to the conviction of individuals, it is interesting to know which sources of safety assurance that have the highest credibility. The survey asked: “Assurance that digital pathology is safe for clinical use can come from many sources. For your own decision, if digital pathology is safe, how much confidence would you get from the following sources?” The results in Figure 7 show that personal experience along with high-quality scientific trials is associated with the highest confidence, whereas CE marking and Food and Drug Administration approval of systems are less assuring, relatively.


Summary of third Nordic symposium on digital pathology.

Lundström C, Waltersson M, Persson A, Treanor D - J Pathol Inform (2016)

Perceived confidence in different sources of safety assurances regarding digital pathology. Personal experience and high-quality trials are considered the most trustworthy sources
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4837798&req=5

Figure 7: Perceived confidence in different sources of safety assurances regarding digital pathology. Personal experience and high-quality trials are considered the most trustworthy sources
Mentions: Validation can be performed, documented, and disseminated in many ways and by several types of stakeholders. As the decision to adopt digital pathology often boils down to the conviction of individuals, it is interesting to know which sources of safety assurance that have the highest credibility. The survey asked: “Assurance that digital pathology is safe for clinical use can come from many sources. For your own decision, if digital pathology is safe, how much confidence would you get from the following sources?” The results in Figure 7 show that personal experience along with high-quality scientific trials is associated with the highest confidence, whereas CE marking and Food and Drug Administration approval of systems are less assuring, relatively.

Bottom Line: Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits.This article is a summary of the third NDP symposium in Linkφping, Sweden.This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use.

View Article: PubMed Central - PubMed

Affiliation: Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden, UK.

ABSTRACT
Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits. The Nordic symposium on digital pathology (NDP) was created to promote knowledge exchange in this area, among stakeholders in health care, industry, and academia. This article is a summary of the third NDP symposium in Linkφping, Sweden. The Nordic experiences, including several hospitals using whole-slide imaging for substantial parts of their primary reviews, formed a fertile base for discussions among the 190 NDP attendees originating from 15 different countries. This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use.

No MeSH data available.